Pharma Journalist -

Pelican BioThermal announced the further expansion of its worldwide reach into Australia and New Zealand, effective immediately. Wilpak Group International will provide sales and…
Read More...

ATAI Life Sciences AG announced an investment in two separate joint ventures (JV) with DemeRx, a clinical stage pharmaceutical company focused on developing ibogaine and noribogaine for…
Read More...

Genialis announced a collaborative partnership with Oncologie, an international, clinical-stage biopharma developing next-generation immunotherapies for cancer. Initial activities will…
Read More...

Sanofi announced the successful completion of its acquisition of Synthorx, Inc. for $68 per share in cash. “The acquisition of Synthorx perfectly aligns with our R&D strategy,…
Read More...

Evotec SE and Indivumed GmbH announced that the companies have entered into a new research collaboration to discover and develop first-in-class therapeutics for the treatment of…
Read More...

Moderna, Inc. a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, and…
Read More...

Catalent welcomed the news that DiaMedica Therapeutics has received U.S. Food and Drug Administration (FDA) approval to commence Phase 2 clinical trials of its lead candidate, DM199,…
Read More...

Roche announced positive topline results from the pivotal Part 2 of the FIREFISH study, evaluating risdiplam in infants aged 1-7 months with Type 1 spinal muscular atrophy (SMA). The…
Read More...

Epizyme, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of TAZVERIK (tazemetostat) for the treatment of adults and pediatric patients…
Read More...

INHIBITOR Therapeutics, Inc. a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics to inhibit progression of cancerous and…
Read More...